Measles Elimination: Identifying Susceptible Sub-Populations to Tailor Immunization Strategies

Viruses. 2019 Aug 20;11(8):765. doi: 10.3390/v11080765.

Abstract

Measles elimination has been identified as a public health priority in Europe for a long time but has not yet been achieved. The World Health Organization (WHO) recommends identification of susceptible sub-populations to target supplementary immunization activities. We used three different sources of information: retrospective samples investigated for measles IgG between 1997 and 2016, vaccine coverage data from the existing electronic registry for birth cohorts 2015 to 1999, and surveillance data from 2009 until 20 July 2019. We calculated susceptibility by birth cohort using seroprevalence data, adjusting vaccine coverage data with reported effectiveness (93% for the first and 97% for the second dose, respectively), and compared it with measles incidence data, aggregated by birth cohorts and districts. Susceptibility levels for persons 10-41 years (birth cohorts 2007-1976) were 10.4% and thus far above the recommended values of WHO (5%). Older birth cohorts were sufficiently protected. Districts with the highest susceptibility estimates corresponded with districts with the highest incidence rates. Birth cohorts with susceptibility levels > 10% showed a 4.7 increased relative risk of having had more than one measles case. We conclude that retrospective serosurveys are a cheap and useful approach in identifying susceptible sub-populations, especially for older birth cohorts whose coverage data remain scarce.

Keywords: measles; serosurvey; surveillance; vaccine coverage.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Antibodies, Viral / blood
  • Child
  • Child, Preschool
  • Disease Eradication
  • Disease Susceptibility
  • Female
  • Humans
  • Immunization
  • Male
  • Measles / blood
  • Measles / prevention & control*
  • Measles / virology
  • Measles Vaccine / administration & dosage
  • Measles Vaccine / immunology
  • Measles virus / genetics
  • Measles virus / immunology*
  • Middle Aged
  • Retrospective Studies
  • Seroepidemiologic Studies
  • Young Adult

Substances

  • Antibodies, Viral
  • Measles Vaccine